1100.6000 11.90 (1.09%)
NSE Oct 07, 2026 15:31 PM
Volume: 202.3K
 

1100.60
1.09%
Geojit BNP Paribas
Strides reported its Q2FY22 revenue at Rs. 721cr, (4.8% QoQ, -9% YoY), enabled by a bounce back in the other regulated markets which was partially offset by an underperformance in the US markets. US markets (34% of total revenues) witnessed a 17% QoQ/-38% YoY...
Strides Pharma Science Ltd. is trading below its 30 day SMA of 1122.0
More from Strides Pharma Science Ltd.
Recommended